Alex Bataller

56PUBLICATIONS

239CO-AUTHORS

Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematological tumoursMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (56)

Sort by Publication Date:

|Jun 11, 2026

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Apr 26, 2026

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Mar 28, 2026

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Mar 12, 2026

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Mar 06, 2026

Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.

Kelly S Chien, Ziyi Li, Luca Lanino

|Feb 12, 2026

Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

Pageof 10

Frequent Collaborators

28 joint publications

Courtney DiNardo

27 joint publications

Tapan M Kadia

25 joint publications

Hagop M Kantarjian

24 joint publications

Guillermo Garcia-Manero

24 joint publications

Naval G Daver

23 joint publications

Nicholas Short

22 joint publications

Farhad Ravandi

22 joint publications

Koji Sasaki

20 joint publications

Elias Jabbour

20 joint publications

Gautam Borthakur

Frequent Collaborators

28 joint publications

Courtney DiNardo

27 joint publications

Tapan M Kadia

25 joint publications

Hagop M Kantarjian

24 joint publications

Guillermo Garcia-Manero